|
This is VAERS ID 310290
|
| VAERS ID: | 310290 | Vaccinated: | 2003-02-13 | | Age: | 17.0 | Onset: | 2003-02-13, Days after vaccination: 0 | | Gender: | Female | Submitted: | 2008-04-18, Days after onset: 1890 | | Location: | | Entered: | 2008-04-21, Days after submission: 3 | |
| Life Threatening Illness? No |
| Died? No |
| Disability? No |
| Recovered? No | | ER or Doctor Visit? No |
| Hospitalized? Yes, 0 days | | Extended hospital stay? No |
| Current Illness: | | Diagnostic Lab Data: Unknown | | Previous Vaccinations: | | Other Medications: Unknown | | Preexisting Conditions: Unknown | | CDC 'Split Type': WAES0804USA03545 | |
| Vaccination | Manufacturer | Lot | Dose | Route | Site | | HPV | UNKNOWN MANUFACTURER | | 0 | IM | UN | |
| Administered by: Unknown Purchased by: Unknown | | Symptoms: Hodgkin's disease | | Write-up: This report is being submitted in response to an request for information. Information has been received from an investigator concerning a 17 year old white female who entered a study title as stated above. On 13-FEB-2003, 31-MAR-2008 and 25-AUG-2003 the patient was vaccinated IM with a first, second and third dose of GARDASIL, respectively. The first report of Hodgkin's disease was at the month 12 visit, which occurred on 16-FEB-2004. At that time, the disease was reported to be active with a start date in 2003. The patient was hospitalized. An annotation related to this event reported the subject no longer received treatment (stopped August 2004). The subject received "cytotoxin" and radiation therapy. No other medical history was reported on this patient. No serious clinical adverse experiences were reported for this patient. There was no additional information regarding Hodgkin's disease. On 05-OCT-2006 the patient completed the study. It was reported that per protocol because the episode of Hodgkin's disease was not vaccine related and reported beyond the follow-up period for adverse experiences, the Hodgkin's disease was not reported as an adverse experience but is reported as medical history in the protocol study base. The reporting investigator felt that Hodgkin's disease were not related to study therapy. Additional information has been requested. |
|
|
New Search
|
Link To This Search Result:
http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=310290
|
|
|
